Fasudil is a pharmaceutical compound primarily known as a Rho kinase (ROCK) inhibitor. Originally developed for the treatment of cerebral vasospasm, it has shown potential in various other medical conditions, including cardiovascular diseases and neurological disorders. In recent years, its role in cancer therapy has garnered significant attention.
